About Neogen
Neogen is a publicly listed company based in Lansing (United States) founded in 1982, and was acquired by Kersia in April 2025. Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing. Neogen has raised $700 thousand across 1 funding round from investors including Kersia and Innovative Ventures. The company has 2,970 employees. Neogen has completed 13 acquisitions, including Abtek Biologicals, Adgen and Delf. Its website neogen.com draws about 178 thousand monthly visits. Its Indian entity Neogen Food And Animal Security (India) Private Limited reported revenue of ₹39.10 Cr. Neogen offers products and services including AccuPoint®, Petrifilm®, and Igenity®. Its focus areas include Life Sciences, Genomics, Enabling Technologies and Kits and Reagents. Its competitors include Parse Biosciences, Fluent BioSciences and RareCyte; 3 of its 3 listed competitors have raised funding.
Company details
Neogen was founded in 1982 in Lansing, United States, and operates in the biotechnology sector focused on food and animal safety. Dehydrated culture media and diagnostic kits are produced by the Food Safety Division for detecting foodborne bacteria, natural toxins, genetic modifications, allergens, drug residues, plant diseases, and sanitation issues. The Animal Safety Division provides diagnostics, veterinary instruments, pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.
- Indian entity revenue₹39.10 Cr
FY 2025 · +38% YoY
- Indian entity net profit₹2.25 Cr
FY 2025 · 6% margin
- Indian entity EBITDA₹4.72 Cr
FY 2025 · 12% margin
- Total Equity Funding$700K (USD)
in 1 rounds
- Latest Funding Round$700K (USD), Series A
Jul 1988
- InvestorsKersia
& 1 more
- Employee Count2,970
- Investments & AcquisitionsAbtek Biologicals
& 12 more
- Acquired byKersia
(Apr 2025)
Associated legal entities of Neogen
Neogen operates through Neogen Food And Animal Security (India) Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Neogen Food And Animal Security (India) Private Limited CIN U74120KL2008PTC050404 | Active | 14 Jan 2008 | Ernakulam, Kerala | ₹39.1 Cr | 77 | 5 | View details |
Products & Services of Neogen
Neogen offers a comprehensive portfolio of products and services, including AccuPoint®, Petrifilm®, and Igenity®.
ATP detection swab for surface hygiene testing
Plates for rapid bacterial enumeration in food samples
Genomic profiles for livestock genetic trait analysis
Funding Insights of Neogen
Neogen has successfully raised a total of $700K through 1 strategic funding round. The most recent funding activity was a Series A round of $700 thousand completed in July 1988. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $700,000
- Total Rounds 1
- Last Round Series A — $700,000
- First Round $700,000
(Jul 1988)
- Investors Count 1
All 1 funding rounds of Neogen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 1988 | $700,000 | Series A | – | Innovative Ventures | – |
2 investors in total: 2 institutional.
Investors in Neogen
Neogen has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Kersia and Innovative Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| ivipe.com | ||||
Provider of food safety testing services | 1938 | kersia-group.com | Dinard, France |
Investor details for Neogen
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Neogen Food And Animal Security (India) Private Limited (Neogen)
Neogen Food And Animal Security (India) Private Limited is the primary company behind Neogen. The board of Neogen Food And Animal Security (India) Private Limited currently have 5 directors; the longest-serving is Robert Elliott Langley, appointed in 2020. 14 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Robert Elliott Langley DIN 08897064 | Director | 16 Nov 2020 | 5 yrs 11 mo | Neogen Food And Animal Security (India) Private Limited |
| Mrinal Kumar Sharma DIN 03566751 | Director | 24 Jun 2025 | 1 yr 4 mo | Neogen Food And Animal Security (India) Private Limited |
| Amy Meredith Rocklin DIN 11332501 | Additional Director | 12 Dec 2025 | 10 mo | Neogen Food And Animal Security (India) Private Limited |
| William Joseph Waelke DIN 11332154 | Additional Director | 12 Dec 2025 | 10 mo | Neogen Food And Animal Security (India) Private Limited |
| Andrew William Holmes DIN 11249822 | Additional Director | 12 Dec 2025 | 10 mo | Neogen Food And Animal Security (India) Private Limited |
People of Neogen
146 people are tracked at Neogen (49 in leadership, 9 in board & advisors, 88 in team); the tracked headcount is 2,970.
| Name | Role | Group |
|---|---|---|
Jason Lilly | Vice President, Americas & Australia, New Zealand | Leadership |
Adam Stanenas | Senior Director, Global Operational Excellence And Animal Safety Operations. | Leadership |
Melody Noel | Director Of Supply Chain Operations | Leadership |
Michael Quate | Sales Director | Leadership |
Matthew Young | Director Of Business Process Transformation | Leadership |
Simon H. | Director, Global Pricing And Sales Effectiveness | Leadership |
Kenny Stauffer | Director Of Beef Genomic Sales | Leadership |
Jim Walter | Vice President Of Global Operations | Leadership |
James Topper | Director Of Business Development - Water Diagnostic Products | Leadership |
Chris Sefcheck | Director, Financial Reporting And Technical Accounting | Leadership |
John Tatum | Vice President - Operations And Business Development | Leadership |
Fredrik Eliason | Director Of Business Development - Processed Foods | Leadership |
Harnek Singh | Director Of Business Development - Middle East | Leadership |
James Quill | Director, Product Operations & Customer Success | Leadership |
Shelley Pope | Director Supply Chain Management | Leadership |
Melissa Herbert | Vice President | Leadership |
John Adent | CEO & President | Leadership |
Eric Suwandinata | Global Sourcing Director For Direct- And Indirect Materials | Leadership |
Brian Franklin | Managing Director, Andean Region | Leadership |
Bill Waelke | Vice President, Investor Relations & Treasury | Leadership |
126 more people are available in the full profile.
Complete people profiles for Neogen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Neogen
Neogen is a publicly listed company on the NASDAQ with ticker symbol NEOG in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date11 Mar 2015
- Listed onNASDAQ: NEOG
- Listed entityNeogen Corporation
- Exchange sectorHealth technology
- ISINUS6404911066
- Share price$11.73 (-2.25% on the day) · 2026-10-13
- Market capitalisation$2.56B
- EPS (diluted, trailing year)$-0.26
- Volume (last session)2,338,561
Financials of Neogen
Figures of Neogen Food And Animal Security (India) Private Limited, the primary company behind Neogen, for FY 2025. Revenue was ₹39.10 Cr (+38% year on year). Net profit was ₹2.25 Cr (6% margin). EBITDA was ₹4.72 Cr (12% margin). Revenue has grown at a compounded annual rate of +31% over three years and +21% over five years.
- ₹39.10 CrRevenue · FY 2025 · +38% YoY
- ₹2.25 CrNet profit · 6% margin
- ₹4.72 CrEBITDA · 12% margin
- ₹96.8 LakhPaid-up capital
- 77Employees (provident fund records)
- +31%Revenue CAGR, 3 years
- +21%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $870.4M | -$7.9M | $107.2M |
| 2024 | $894.7M | -$1.09B | $135.1M |
| 2023 | $924.2M | -$9.4M | $198.7M |
| 2022 | $822.5M | -$22.9M | $125.9M |
| 2021 | $527.2M | $48.3M | $82.3M |
Balance sheet, profit and loss, cash flow and ratios of Neogen Food And Animal Security (India) Private Limited are on its company page.
Detailed financial statements for Neogen
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neogen
Neogen has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include Abtek Biologicals, Adgen and Delf.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Speciality chemicals are manufactured and supplied by Delf. | delf-uk.com | Birkenhead, United Kingdom | 2006 | Dec 2021 | •••• | |
Analytical test kits and reagents are supplied for food analysis. | megazyme.com | Bray, Ireland | 1988 | Jan 2021 | •••• | |
Diagnostic products for medical use are manufactured in Chile. | magiar.cl | Chile | 1998 | Apr 2020 | •••• | |
Manufacturer of reagents and dyes kits for research purposes | abtekbio.com | Liverpool, United Kingdom | 1981 | Feb 2020 | •••• | |
Food and feed safety diagnostics equipment is distributed globally. | diessechem.com | Milano, Italy | 1993 | Jan 2020 | •••• | |
Marketing services for animal food products are provided. | magiar.com.ar | Garin, Argentina | 1991 | Jan 2020 | •••• | |
Genomics services are provided for the livestock industry. | deltagenomics.com | Edmonton, Canada | 2011 | Jan 2019 | •••• | |
Genetic evaluations and data management services for livestock are offered. | livestockgenetics.net | 2011 | Sep 2018 | •••• | ||
Insecticides, larvicides, rodenticides, and fertilizers are produced by ROGAMA. | rogama.com.br | Pindamonhangaba, Brazil | 1979 | Dec 2016 | •••• | |
Chemical biocides and disinfectants are manufactured and supplied. | quatchem.com | Rochdale, United Kingdom | 2007 | Dec 2016 | •••• |
Complete acquisition details for Neogen
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Neogen
14 dated milestones of Neogen across 43 years, from founding to its latest funding, stage changes and deals.
- Founded Neogen is founded.
- Funding First funding round of $700K.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Quat-Chem.
- Acquisition Acquires ROGAMA.
- Acquisition Acquires Livestock Genetic Services.
- Acquisition Acquires Delta Genomics.
- Acquisition Acquires MAGIAR FEED.
- Acquisition Acquires Diessechem.
- Acquisition Acquires Abtek Biologicals.
- Acquisition Acquires Magiar Chilena.
- Acquisition Acquires Megazyme.
- Acquisition Acquires Delf.
- Exit Acquired by Kersia.
Competitors of Neogen
Neogen has 3 listed competitors in our database, 3 of them funded. They include Parse Biosciences, Fluent BioSciences and RareCyte.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| parsebiosciences.com | 2018 | Seattle, United States | $100.26M | RNA-sequencing transcriptome kits for health data analysis are developed. | ||
| fluentbio.com | 2018 | Watertown, United States | $19M | Proprietary reagents for single-cell genetic analysis are developed. | ||
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood |
Detailed competitors of Neogen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Neogen
The website of Neogen (neogen.com) receives about 177.9K visits a month.
- Monthly visits177.9K
▼ 11.1% vs previous month
Websites whose visitors overlap most with Neogen. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hardydiagnostics.com | 100% | #583,854 | View details | ||
| vicam.com | 95% | 5.2K | #3,678,758 | View details | |
operon.com | operon.com | 92% | – | ||
| oxoid.com | 91% | View details | |||
| condalab.com | 84% | #726,805 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Neogen
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Neogen (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neogen
Complete news archive for Neogen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neogen
Neogen was founded in 1982 and raised its 1st funding round 6 years after it was founded.
Neogen is headquartered in Lansing, United States. It is registered at Lansing, Michigan, United States.
Neogen is a funded company, having raised a total of $700K across 1 funding round to date. The company's 1st funding round was a Series A of $700K, raised on Jul 1988.
Neogen has 2,970 employees.
The primary company behind Neogen, Neogen Food And Animal Security (India) Private Limited, reported revenue of ₹39.10 Cr for FY 2025, up 38% year on year.
Neogen was founded in 1982 in Lansing, United States, and operates in the biotechnology sector focused on food and animal safety. Dehydrated culture media and diagnostic kits are produced by the Food Safety Division for detecting foodborne bacteria, natural toxins, genetic modifications, allergens, drug residues, plant diseases, and sanitation issues. The Animal Safety Division provides diagnostics, veterinary instruments, pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.
Neogen's top competitors include Parse Biosciences, RareCyte and Fluent BioSciences.
Neogen offers AccuPoint®, Petrifilm®, and Igenity®.
Yes, Neogen is publicly traded on NASDAQ under the ticker symbol NEOG.
Neogen has made 13 acquisitions, including Abtek Biologicals, Adgen, and Delf.
Neogen has 2 investors. Key investors include Kersia, and Innovative Ventures.
Neogen operates through Neogen Food And Animal Security (India) Private Limited.